Hims & Hers Health, Inc. (HIMS) Debt to Equity Ratio: 2.34
Is Hims & Hers Health, Inc.’s debt to equity ratio high or low?
Hims & Hers Health, Inc.'s debt to equity ratio of 2.34 is 478% above its 5-year average of 0.40, near the high end of its 5-year range (0.00–2.34).
The debt to equity ratio for Hims & Hers Health, Inc. (HIMS) is 2.34 as of Wednesday, June 10, 2026. It is above its 12-month average by 98.31% (1.18).
HIMS Debt to Equity Ratio Chart
HIMS Average Debt to Equity Ratio Chart
HIMS Current vs Average Debt to Equity Ratio Chart
HIMS Debt to Equity Ratio Metrics
DEBT TO EQUITY RATIO
2.34
DEBT TO EQUITY RATIO AVG TTM
1.18
DEBT TO EQUITY RATIO AVG 3Y
0.60
DEBT TO EQUITY RATIO AVG 5Y
0.40
DEBT TO EQUITY RATIO AVG 10Y
0.40
DEBT TO EQUITY RATIO AVG 15Y
0.40
DEBT TO EQUITY RATIO AVG 20Y
0.40
CURRENT VS TTM AVG
+98.31%
CURRENT VS 3Y AVG
+288.38%
CURRENT VS 5Y AVG
+477.78%
CURRENT VS 10Y AVG
+477.78%
CURRENT VS 15Y AVG
+477.78%
CURRENT VS 20Y AVG
+477.78%
HIMS Competitors' Debt to Equity Ratio
| NAME | MARKET CAP | DEBT TO EQUITY RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | — | 2.34 | 1.18 | 0.60 | 0.40 |
| Bio-Rad Laboratories, Inc. (BIO) | $7.89B | 0.21 | 0.21 | 0.18 | 0.13 |
| Charles River Laboratories International, Inc. (CRL) | $9.06B | 0.97 | 0.88 | 0.91 | 0.99 |
| Align Technology, Inc. (ALGN) | $12.56B | 0.03 | 0.03 | 0.03 | 0.03 |
| Hologic, Inc. (HOLX) | $16.97B | 0.52 | 0.52 | 0.55 | 0.69 |
| Moderna, Inc. (MRNA) | $18.40B | 0.22 | 0.15 | 0.11 | 0.10 |
| BioNTech SE (BNTX) | $21.81B | 0.01 | 0.01 | 0.01 | 0.04 |
| Mettler-Toledo International Inc. (MTD) | $22.85B | -99.14 | 48.23 | 26.06 | 17.96 |
| Waters Corporation (WAT) | $23.83B | 0.58 | 0.76 | 1.73 | 2.93 |
| Veeva Systems Inc. (VEEV) | $26.73B | 0.01 | 0.01 | 0.01 | 0.02 |
Financial Health
Debt/Equity
2.34
Current Ratio
1.90
Hims & Hers Health, Inc. Debt to Equity Ratio Formula & Definition
Debt to Equity measures financial leverage by comparing total debt to shareholders' equity.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Hims & Hers Health, Inc. Debt to Equity Ratio FAQ
- What is the debt to equity ratio for Hims & Hers Health, Inc. (HIMS)?
- The debt to equity ratio for HIMS stock is 2.34.
- Is Hims & Hers Health, Inc.'s debt to equity ratio high or low?
- Hims & Hers Health, Inc.'s debt to equity ratio of 2.34 is 478% above its 5-year average of 0.40, near the high end of its 5-year range (0.00–2.34).
- What is the TTM average debt to equity ratio for Hims & Hers Health, Inc. (HIMS)?
- The TTM average debt to equity ratio for HIMS stock is 1.18.
- What is the 3Y average debt to equity ratio for Hims & Hers Health, Inc. (HIMS)?
- The 3Y average debt to equity ratio for HIMS stock is 0.60.
- What is the 5Y average debt to equity ratio for Hims & Hers Health, Inc. (HIMS)?
- The 5Y average debt to equity ratio for HIMS stock is 0.40.
- What is the 10Y average debt to equity ratio for Hims & Hers Health, Inc. (HIMS)?
- The 10Y average debt to equity ratio for HIMS stock is 0.40.
- What is the 15Y average debt to equity ratio for Hims & Hers Health, Inc. (HIMS)?
- The 15Y average debt to equity ratio for HIMS stock is 0.40.
- What is the 20Y average debt to equity ratio for Hims & Hers Health, Inc. (HIMS)?
- The 20Y average debt to equity ratio for HIMS stock is 0.40.
Hims & Hers Health, Inc. Debt to Equity Ratio History
| DATE | DEBT TO EQUITY RATIO |
|---|---|
| 2025-12-31 | 2.34 |
| 2024-12-31 | 0.02 |
| 2023-12-31 | 0.03 |
| 2022-12-31 | 0.02 |
| 2021-12-31 | 0.02 |
| 2020-12-31 | 0.00 |
Related Metrics
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. operates a comprehensive digital health platform that seamlessly links individuals with licensed medical professionals for virtual consultations and ongoing care. Through its user-friendly websites and mobile app, the company delivers a diverse portfolio of health and wellness solutions directly to consumers. This includes access to recurring prescription medications, alongside a wide selection of over-the-counter drugs, devices, cosmetics, and dietary supplements. Its core focus areas are general wellness, sexual health, skincare, and hair care. Specific non-prescription offerings span categories such as: Wellness: encompassing items like vitamin C, melatonin, biotin, and collagen protein supplements. Skincare: including products such as moisturizers, serums, and face washes. Sexual Health: providing essentials like condoms, climax delay sprays and wipes, vibrators, and lubricants. Hair Care: offering specialized shampoos, conditioners, scalp scrubs, and topical treatments like minoxidil. Beyond direct sales, Hims & Hers also distributes health and wellness products via wholesale partnerships. The company's headquarters are located in San Francisco, California.
- Sector
- Healthcare
- Industry
- Medical - Equipment & Services
- CEO
- Andrew Dudum